NCT01037517View on ClinicalTrials.gov

Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Multiple MyelomaLymphoma
Interventions
DRUG

Plerixafor

Plerixafor will be administered at 23:00 of Day -1 to experimental subjects at a dose of 240 mcg/kg subcutaneously, and possibly repeated the following day

OTHER

Observation: Nonintervention

Nonintervention group, no drug will be given, observation only

Trial Locations (1)

R3E 0V9

CancerCare Manitoba, Winnipeg

Sponsors
All Listed Sponsors
lead

CancerCare Manitoba

OTHER